14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AGIO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Agios Pharmaceuticals stock price after Monday trading.
(Updated on Apr 22, 2024)

Buy candidate since Apr 22, 2024 PDF

The Agios Pharmaceuticals stock price gained 2.30% on the last trading day (Monday, 22nd Apr 2024), rising from $29.53 to $30.21. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.71% from a day low at $29.50 to a day high of $30.89. The price has risen in 7 of the last 10 days and is up by 9.06% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 76 thousand more shares were traded than the day before. In total, 824 thousand shares were bought and sold for approximately $24.88 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 20.46% during the next 3 months and, with a 90% probability hold a price between $33.73 and $46.80 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AGIO Signals & Forecast

The Agios Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $29.40 and $29.73. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -13.21%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Agios Pharmaceuticals stock

Agios Pharmaceuticals finds support from accumulated volume at $29.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.39 between high and low, or 4.71%. For the last week, the stock has had daily average volatility of 3.52%.

Our recommended stop-loss: $28.46 (-5.80%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 38 days ago.)

Trading Expectations (AGIO) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Agios Pharmaceuticals to open at $30.20, and during the day (based on 14 day Average True Range), to move between $29.05 and $31.37, which gives a possible trading interval of +/-$1.16 (+/-3.83%) up or down from last closing price. If Agios Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 7.67% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $29.94 (0.89%) than the resistance at $31.79 (5.23%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Agios Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Agios Pharmaceuticals stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.711 Buy Candidate Upgraded

Predicted Opening Price for Agios Pharmaceuticals of Tuesday, April 23, 2024

Fair opening price April 23, 2024 Current price
$30.20 ( 0.0331%) $30.21

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AGIO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 31.59 4.57 %
R2 31.06 2.81 %
R1 30.73 1.72 %
Current price: 30.21
Support S1 29.67 -1.79 %
S2 29.34 -2.88 %
S3 28.81 -4.63 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 34.81 15.23 %
R2 32.99 9.20 %
R1 31.79 5.23 %
Current price 30.21
Support S1 29.94 -0.89%
S2 29.78 -1.42%
S3 26.80 -11.29%

FAQ

What is the symbol for Agios Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Agios Pharmaceuticals is AGIO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Agios Pharmaceuticals Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Agios Pharmaceuticals stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Agios Pharmaceuticals Stock?
Agios Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Agios Pharmaceuticals Stock.

What's the current price of Agios Pharmaceuticals Stock?
As of the end of day on the Apr 22, 2024, the price of an Agios Pharmaceuticals (AGIO) share was $30.21.

What is the 52-week high and low for Agios Pharmaceuticals Stock?
The 52-week high for Agios Pharmaceuticals Stock is $35.48 and the 52-week low is $19.80.

What is the market capitalization of Agios Pharmaceuticals Stock?
As of the Apr 22, 2024, the market capitalization of Agios Pharmaceuticals is 1.679B.

When is the next earnings date for Agios Pharmaceuticals?
The upcoming earnings date for Agios Pharmaceuticals is May 02, 2024.
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT